Clinical Trial Update: Al18F-NOTA-LM3 PET/CT in Patients With TIO [NA]

View source ↗

Summary

The clinical trial is recruiting to evaluate Al18F-NOTA-LM3 PET/CT imaging in patients with Tumor-Induced Osteomalacia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumor-induced Osteomalacia

Drugs mentioned

• Al18F-NOTA-LM3 (Al18F-NOTA-LM3)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Tumor-Induced Osteomalacia | NA | Status: RECRUITING